Figure 5 | Scientific Reports

Figure 5

From: MARK4 aggravates cardiac dysfunction in mice with STZ-induced diabetic cardiomyopathy by regulating ACSL4-mediated myocardial lipid metabolism

Figure 5

Effects of MARK4 deficiency on fatty acid oxidation and blood lipid levels in STZ-induced DCM mice. (A–E) Western blot and quantitative analysis of the levels of fatty acid oxidation-related proteins (CPT1A, CPT2, and PPAR-α) (n = 6 samples per group). (F) Blood triglyceride levels in each group (n = 6 samples per group). The data are presented as the means ± SDs. Significant differences are indicated by *P < 0.05, **P < 0.01, and ***P < 0.001.

Back to article page